Home › Non-Muscle Invasive Bladder Cancer › New York
Non-Muscle Invasive Bladder Cancer clinical trials in New York
16 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in New York.
Cities in New York
- New York City10 studies
- Syracuse8 studies
- Queens4 studies
- Greenburgh4 studies
- Staten Island4 studies
- New Rochelle3 studies
- Buffalo3 studies
- The Bronx3 studies
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai, New York
- Weill Cornell Medical Center, New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06503614Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Roswell Park Cancer Institute, Buffalo
- Memorial Sloan Kettering Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0111), New York
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06833073Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Icahn School of Medicine at Mount Sinai (ISMMS) - Mount Sinai Queens - Infusion Center, Astoria
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center - Sidney Kimmel Center for Prostate and Urologic Cancers, New York
- and 3 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Associated Medical Professionals, Syracuse
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- MSK Commack, Commack
- MSK Westchester, Harrison
- Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street)., New York
- and 9 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07206225A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- SUNY Upstate Med Univ, Syracuse
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07309445A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06733363Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York
- University of Rochester, Department of Urology, Rochester
- Associated Medical Professionals of NY, PLLC, Syracuse
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- New York University (NYU), New York
- Weill Cornell Medicine, New York
- Icahn School of Medicine at Mount Sinai, New York
- and 4 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), East White Plains
- Columbia University (Data Collection Only), New York
- and 2 more
RecruitingPhase 3
Ages 21 and older · All sexes · Updated Aug 20, 2026 · NCT06929286Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT05126472LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Albany Medical College, Albany
- Roswell Park Cancer Institute, Buffalo
- Mount Sinai Medical Center, New Haven
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG
- SUNY Upstate Medical University, Syracuse
RecruitingPhase 1/2
Ages 18 to 85 · All sexes · Updated Mar 27, 2026 · NCT06800963Blue Light Cystoscopy With Cysview® Registry
- NYU Langone's Perlmutter Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT02660645Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
- Site 02-015 - Associated Medical Professionals of New York, Syracuse
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 24, 2025 · NCT03945162From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.